30 leading drug companies to set 240 billion won of R&D budget.

Published: 2001-05-22 07:00:00

Updated: 2001-05-22 07:00:00

30 leading domestic drug companies allocated 6% of their sales revenue to the R&D budget this year, about 20% up from the previous year, implying an aggressive attempt to leap into the advanced country, a survey unveiled.

The survey disclosed on May 17 showed that the total sales amount genera...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK